ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Merus NV

Merus NV (2GH)

41.40
-2.00
(-4.61%)
Closed December 05 4:00PM
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
41.40
Bid
41.00
Ask
42.00
Volume
542
43.20 Day's Range 43.80
21.40 52 Week Range 58.50
Previous Close
43.40
Open
43.80
Last Trade
47
@
43.2
Last Trade Time
Average Volume (3m)
114
Financial Volume
-
VWAP
-

2GH Latest News

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

Merus annonce sa participation aux prochaines journées Investisseurs

Merus annonce sa participation aux prochaines journées Investisseurs UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 07 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une...

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Unternehmen aus...

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 05 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.8-4.1666666666743.247437546.60089286DE
4-8.6-17.25051.540.49946.46118598DE
12-4-8.8105726872245.451.540.411447.6509915DE
26-5.2-11.158798283346.657.540.415348.80237835DE
5220.00000193.457952965321.39999958.521.39999917044.3573342DE
15617.673.949579831923.858.51916541.98058262DE
26017.673.949579831923.858.51916541.98058262DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
17DArcadia Biosciences Inc
5.15 €
(99.61%)
10.94k
1KPAProtara Therapeutics Inc
5.90 €
(75.60%)
16.79k
1ZY0Medaro Mining Corp
0.17 €
(63.46%)
54.1k
TE9Teco 2030 ASA
0.0398 €
(61.79%)
1.04M
L7C2Windfall Geotek Inc
0.006 €
(50.00%)
18k
NL8Genesis Ai Corp
0.0056 €
(-58.82%)
10k
0PV2Moovly Media Inc
0.0025 €
(-58.33%)
859
CNWCodon AG
0.0065 €
(-40.91%)
1.5k
BLEBluebird bio Inc
0.4205 €
(-40.13%)
233.06k
DW8Tantalex Lithium Resources Corp
0.0115 €
(-39.47%)
2k
D7GNel ASA
0.2679 €
(0.15%)
5.5M
AXIAtos SE
0.20 €
(-36.51%)
4.95M
PLUNPlug Power Inc
2.2955 €
(13.55%)
3.17M
R9BDeFi Technologies Inc
3.06 €
(-6.13%)
2.98M
TUI1Tui AG
8.318 €
(5.26%)
2.21M

Discussion

View Full Feed
THEBEASTMUGABI THEBEASTMUGABI 3 minutes ago
Had to google Double top Breakout JJ.  I'm learning slowly, only by definitions though.  I can't read charts so I rely on you all.   It said double top breakout was a bearish sign and you put a bullish sign up.  Not doubting you, I'm just trying to understand.  Keep it up, I appreciate all the comme
IONQ
boominator boominator 3 minutes ago
LANL researchers complete HALEU criticality experiment
Friday, 29 November 2024

The Deimos experiment at Los Alamos National Laboratory is the first criticality experiment using high assay low-enriched uranium fuel to be carried out in the USA in more than 20 years, and will he
LTBR
Clark6290 Clark6290 4 minutes ago
Are you still sleeping Amigo
FNMA
3331 3331 4 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT ACTIPATCH ON DR. OZ:
https://www.facebook.com/share/v/18NzZcGQVm/
varmit varmit 4 minutes ago
I nrver did get my tiger hemp beer dividends 
NSAV
MrSmith101 MrSmith101 5 minutes ago
I’m not sure declaes understands what DD means lol. Declaes thinks Due Diligence is just blurting out a random number. There’s no basis for 25 million in revenue even without considering operating costs. Plus paying Edgewater’s medicaid fraud settlement that’s in the millions.
GRST
Snake River Dog Snake River Dog 5 minutes ago
Possible Mention In Wall Street!! This .0001 Stock!! added to this one today. (BYOC.0001) Looking for a nice possible Bounce!! at some Point!! Please read latest News!! 11/12/24

Beyond Commerce Looks to Move Forward with Growth Opportunities After Reaching Confidential Settlements in
BYOC
ChannelTrader ChannelTrader 6 minutes ago
Trump Picks Popular Fox News Contributor for Key Post

https://truthpress.com/news/trump-picks-popular-fox-news-contributor-for-key-post/?utm_source=truthpress.beehiiv.com&utm_medium=newsletter&utm_campaign=unitedhealthcare-ceo-shooter-unmasked&_bhlid=3ad48e204373f53ad7f000726425e8dc72
PantyPuller PantyPuller 7 minutes ago
I mean it was funny a couple times, but now it's just annoying..
VDRM
4retire 4retire 8 minutes ago
Thanks Dallas
NVDA
rickstereo3333 rickstereo3333 8 minutes ago
If there's, to date, nothing major to report, ie an IDE submission date, what would be the point of Pr'ing irrelevant info from the supposedly now concluded Sprint meetings?

If Mk does that the detractors on here will simply "pivot" to the new narrative which will be lambasting the co
RDGL
Real McCoy Real McCoy 8 minutes ago
Well you know it’s not reading comprehension as I’ve bested you here, as you’re out 100%.

What else you wanna talk about?
nwtf nwtf 9 minutes ago
All of this happening and not one leak??? If this were true this issue wouldnt be subzero. Nice delusion youve got going.
ERHE
jay_tee jay_tee 9 minutes ago
The only definite we have whether it's in RNVAs filings or FOXOs, is Seamus taking care of that debt due . Sad we have to analyze another company's filings for pertinent information..
RNVA
mascale mascale 9 minutes ago
The first month of the announced timeline is up in a few days. Imminent announced details are now more likely. Then the international stature of Qatar is light-years advanced, just since Monday.
HIRU
Smattchew Smattchew 11 minutes ago
Depends are you going to ignore the question outright with purposeful ignorance or is it actually a reading comprehension deficit?
nwtf nwtf 12 minutes ago
Link for said deals? Bet you dont have one. So you made up another lie.
ERHE
XMaster2023 XMaster2023 12 minutes ago
Short talking to a short.
NWBO
Researchfyi Researchfyi 12 minutes ago
Over the years there are lists of things above zero that have impacted the share price. None of them resulted in impacting on lqmt’s share price in a disproportionate manner. The only thing disproportionate were the expectations.

The outsiders are definitely not to blame. Neither are
LQMT
Clark6290 Clark6290 13 minutes ago
Amigo, why you sleeping
Stay awake, watch the charts
FNMA
Lime Time Lime Time 14 minutes ago
He needs to still get this to a spot where it can be traded on every brokerage. That's coming in 2025. Still can't buy this on IBKR.

I agree, times are changing for the better now. Money will start flowing again 🚀
IBKR
rado rado 15 minutes ago
Are there other stock boards on here worth following?

Your Recent History

Delayed Upgrade Clock